Additional file 1 of Use of acceptable daily intake (ADI) as a health-based benchmark in nutrition research studies that consider the safety of low-calorie sweeteners (LCS): a systematic map

Additional file 1: Supplemental Table 1. LCS and their respective ADIs, as designated by the FDA, EFSA/SCF, and WHO/JECFA. Supplemental Table 2. Studies of direct relevance in which authors use the ADI as a safety benchmark to determine an appropriate intake for a controlled exposure. Supplemental Table 3. Studies of direct relevance in which authors compare an EDI to an ADI to estimate the MOS in the population of interest. Supplemental Table 4. Studies of direct relevance in which authors compare an effect (or no-effect) level to an ADI to discuss safety. Supplemental Table 5. Studies of contextual relevance. Supplemental Table 6. Studies excluded from mapping during full-text review.